Jane Street’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$87.5K Buy
36,900
+24,800
+205% +$85.9K ﹤0.01% 10711
2025
Q4
$62.7K Buy
+12,100
New +$58.6K ﹤0.01% 10415
2021
Q4
Sell
-15,300
Closed -$218K 10617
2021
Q3
$218K Sell
15,300
-1,700
-10% -$26.4K ﹤0.01% 8725
2021
Q2
$283K Buy
+17,000
New +$317K ﹤0.01% 8248

Other funds holding ORGO

Jane Street's ORGO Position: Q1 2026 in Review

Jane Street reduced its Organogenesis Holdings (ORGO) stake by 85% in Q1 2026, selling an estimated $2.61M and leaving 129,333 shares worth $307K. The position accounts for ﹤0.01% of the portfolio, ranked #9188.

Jane Street first reported a position in ORGO in Q2 2020 and has held it in 15 quarters since. The position peaked at $4.57M in Q4 2025. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

  • Jane Street held 129,333 shares of Organogenesis Holdings worth $307K as of Q1 2026.
  • Jane Street sold 752,354 Organogenesis Holdings shares in Q1 2026, an estimated $2.61M.
  • Organogenesis Holdings made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #9188 holding.
  • Jane Street first reported a position in Organogenesis Holdings in Q2 2020 and has held it in 15 quarters since.
  • Jane Street's Organogenesis Holdings position peaked at $4.57M in Q4 2025.
  • 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.